Authors:
WALLIS DE
LEWIS BE
MESSMORE H
WEHRMACHER WH
Citation: De. Wallis et al., HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS SYNDROME, Clinical and applied thrombosis/hemostasis, 4(3), 1998, pp. 160-163
Citation: Wh. Wehrmacher et al., TICLOPIDINE AND CLOPIDOGREL - DO THEY HAVE DIRECT VASCULAR EFFECTS, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 225-225
Citation: Wh. Wehrmacher et H. Messmore, THROMBOPHILIA - CONSIDER HOMOCYSTEINE TOO, Clinical and applied thrombosis/hemostasis, 3(2), 1997, pp. 147-148
Citation: Wh. Wehrmacher et Hl. Messmnore, THROMBOTIC AND BLEEDING COMPLICATIONS OF ELECTRIC-SHOCK, Clinical and applied thrombosis/hemostasis, 2(3), 1996, pp. 219-221
Authors:
SINGH S
JOHNSON PI
LEE RE
ORFEI E
LONCHYNA VA
SULLIVAN HJ
MONTOYA A
TRAN H
WEHRMACHER WH
WURSTER RD
Citation: S. Singh et al., TOPOGRAPHY OF CARDIAC GANGLIA IN THE ADULT HUMAN HEART, Journal of thoracic and cardiovascular surgery, 112(4), 1996, pp. 943-953
Citation: Wh. Wehrmacher, SUDDEN-INFANT-DEATH-SYNDROME AND CIRCADIAN-RHYTHM, JAMA, the journal of the American Medical Association, 274(12), 1995, pp. 944-944
Citation: Hl. Messmore et al., UTILITY OF THE HEPTEST AND A CHROMOGENIC SUBSTRATE METHOD TO ASSESS ANTICOAGULATION IN PATIENTS REFRACTORY TO HEPARINIZATION BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME METHOD, Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 351-352
Citation: Hl. Messmore et Wh. Wehrmacher, THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS, Seminars in thrombosis and hemostasis, 19, 1993, pp. 97-100
Citation: Wc. Randall et Wh. Wehrmacher, EARLY AND LATE ARRHYTHMIAS AFTER THE FONTAN OPERATION - PREDISPOSING FACTORS AND CLINICAL CONSEQUENCES, British Heart Journal, 69(6), 1993, pp. 572-572